title: The proliferative and morphologic responses of a colon carcinoma cell line (LIM 1215) require the production of two autocrine factors.
abstract: The role of autocrine growth factors in tumor cell growth has been difficult to prove. Our results indicate that more than one autocrine factor is required for the autonomous growth of the LIM 1215 colonic carcinoma cell line. Furthermore, the morphologic changes induced by epidermal growth factor (EGF) are also density dependent and appear to require a synergistic autocrine factor. The serum-free proliferation of the colonic carcinoma cell line LIM 1215 depends on cell density and the presence of EGF (A. Sizeland, S. Bol, and A.W. Burgess, Growth Factors 4:129-143, 1991). At cell densities below 10(4)/cm2, conditioned medium (from cells at a density of 10(5)/cm2) was required for the cells to elicit a mitogenic response to exogenous EGF. At higher cell densities (10(5)/cm2), the cells were independent of both exogenous EGF and conditioned medium. In addition, the EGF receptor was found to be phosphorylated on tyrosine in LIM 1215 cells proliferating at high density, suggesting that the autocrine production of transforming growth factor alpha (TGF alpha) and subsequent ligation to the EGF receptor was occurring. The proliferation of cells at high density was partly inhibited by TGF alpha antibodies but was almost completely inhibited by an antisense oligonucleotide to TGF alpha. The antisense inhibition could be overcome by the addition of EGF, indicating that the effect of the antisense TGF alpha oligonucleotide was on the production of autocrine TGF alpha. LIM 1215 cells were also observed to undergo morphologic changes (spreading and actin cable organization) in response to EGF. These changes were density dependent, but they occurred with a cell density dependence different from that of the proliferative response. These results suggest two possibilities: that the morphologic changes and proliferative responses have different sensitivities to the autocrine factors or that the actions of the autocrine factors are mediated through different signal transduction pathways.
authors.affiliation: Melbourne Tumour Biology Branch, Ludwig Institute for Cancer Research, Victoria, Australia.
authors.forename: A M
authors.initials: AM
authors.lastname: Sizeland
authors.forename: A W
authors.initials: AW
authors.lastname: Burgess
mesh_terms: D000199:Actins / Q000032:analysis; D000595:Amino Acid Sequence; D016375:Antisense Elements (Genetics); D001483:Base Sequence; D015153:Blotting, Western; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D003110:Colonic Neoplasms / Q000235:genetics / Q000473:pathology* / Q000503:physiopathology; D003470:Culture Media; D004261:DNA Replication / Q000187:drug effects; D004815:Epidermal Growth Factor / Q000235:genetics* / Q000494:pharmacology / Q000502:physiology; D006801:Humans; D007700:Kinetics; D008969:Molecular Sequence Data; D015345:Oligonucleotide Probes; D013936:Thymidine / Q000378:metabolism; D016211:Transforming Growth Factor alpha / Q000235:genetics* / Q000502:physiology
chemical_list: D000199:Actins; D016375:Antisense Elements (Genetics); D003470:Culture Media; D015345:Oligonucleotide Probes; D016211:Transforming Growth Factor alpha; D004815:Epidermal Growth Factor; D013936:Thymidine